These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22956240)

  • 1. Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients.
    Harberts E; Datta D; Chen S; Wohler JE; Oh U; Jacobson S
    J Neuroimmune Pharmacol; 2013 Mar; 8(1):51-7. PubMed ID: 22956240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
    Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocator protein PET imaging for glial activation in multiple sclerosis.
    Oh U; Fujita M; Ikonomidou VN; Evangelou IE; Matsuura E; Harberts E; Fujimura Y; Richert ND; Ohayon J; Pike VW; Zhang Y; Zoghbi SS; Innis RB; Jacobson S
    J Neuroimmune Pharmacol; 2011 Sep; 6(3):354-61. PubMed ID: 20872081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Herranz E; Treaba CA; Barletta VT; Mehndiratta A; Ouellette R; Sloane JA; Ionete C; Babu S; Mastantuono M; Magon S; Loggia ML; Makary MM; Hooker JM; Catana C; Kinkel RP; Nicholas R; Klawiter EC; Magliozzi R; Mainero C
    Brain; 2024 Jul; 147(7):2566-2578. PubMed ID: 38289855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed-affinity binding in humans with 18-kDa translocator protein ligands.
    Owen DR; Gunn RN; Rabiner EA; Bennacef I; Fujita M; Kreisl WC; Innis RB; Pike VW; Reynolds R; Matthews PM; Parker CA
    J Nucl Med; 2011 Jan; 52(1):24-32. PubMed ID: 21149489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
    Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
    Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation.
    Kreisl WC; Jenko KJ; Hines CS; Lyoo CH; Corona W; Morse CL; Zoghbi SS; Hyde T; Kleinman JE; Pike VW; McMahon FJ; Innis RB;
    J Cereb Blood Flow Metab; 2013 Jan; 33(1):53-8. PubMed ID: 22968319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28.
    Owen DR; Yeo AJ; Gunn RN; Song K; Wadsworth G; Lewis A; Rhodes C; Pulford DJ; Bennacef I; Parker CA; StJean PL; Cardon LR; Mooser VE; Matthews PM; Rabiner EA; Rubio JP
    J Cereb Blood Flow Metab; 2012 Jan; 32(1):1-5. PubMed ID: 22008728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker.
    Kreisl WC; Fujita M; Fujimura Y; Kimura N; Jenko KJ; Kannan P; Hong J; Morse CL; Zoghbi SS; Gladding RL; Jacobson S; Oh U; Pike VW; Innis RB
    Neuroimage; 2010 Feb; 49(4):2924-32. PubMed ID: 19948230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
    Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
    Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
    Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.
    Owen DR; Howell OW; Tang SP; Wells LA; Bennacef I; Bergstrom M; Gunn RN; Rabiner EA; Wilkins MR; Reynolds R; Matthews PM; Parker CA
    J Cereb Blood Flow Metab; 2010 Sep; 30(9):1608-18. PubMed ID: 20424634
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kobayashi M; Jiang T; Telu S; Zoghbi SS; Gunn RN; Rabiner EA; Owen DR; Guo Q; Pike VW; Innis RB; Fujita M
    J Cereb Blood Flow Metab; 2018 Mar; 38(3):393-403. PubMed ID: 28322082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of alcoholism and cholesterol on TSPO binding in brain: PET [
    Kim SW; Wiers CE; Tyler R; Shokri-Kojori E; Jang YJ; Zehra A; Freeman C; Ramirez V; Lindgren E; Miller G; Cabrera EA; Stodden T; Guo M; Demiral ŞB; Diazgranados N; Park L; Liow JS; Pike V; Morse C; Vendruscolo LF; Innis RB; Koob GF; Tomasi D; Wang GJ; Volkow ND
    Neuropsychopharmacology; 2018 Aug; 43(9):1832-1839. PubMed ID: 29777199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [
    Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E
    J Neuroimmunol; 2019 Sep; 334():577000. PubMed ID: 31260948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease.
    Kreisl WC; Lyoo CH; Liow JS; Wei M; Snow J; Page E; Jenko KJ; Morse CL; Zoghbi SS; Pike VW; Turner RS; Innis RB
    Neurobiol Aging; 2016 Aug; 44():53-61. PubMed ID: 27318133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.
    Datta G; Violante IR; Scott G; Zimmerman K; Santos-Ribeiro A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Matthews PM
    Mult Scler; 2017 Oct; 23(11):1469-1478. PubMed ID: 27903933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
    Sucksdorff M; Matilainen M; Tuisku J; Polvinen E; Vuorimaa A; Rokka J; Nylund M; Rissanen E; Airas L
    Brain; 2020 Dec; 143(11):3318-3330. PubMed ID: 33006604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
    Nack A; Brendel M; Nedelcu J; Daerr M; Nyamoya S; Beyer C; Focke C; Deussing M; Hoornaert C; Ponsaerts P; Schmitz C; Bartenstein P; Rominger A; Kipp M
    Cells; 2019 Jan; 8(2):. PubMed ID: 30696113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.